Prof. Dr. Dirk Reinhardt
1 clinical trials · Sponsor
◉ Watch Prof. Dr. Dirk Reinhardt
| Record | Firm | Date |
|---|---|---|
| International Phase I Trial of Dinutuximab Beta With VDC/IE in GD2-Positive Ewing Sarkoma (NCT06839703) | Prof. Dr. Dirk Reinhardt | 2025-03-01 |
Track Prof. Dr. Dirk Reinhardt automatically
Every clearance here is in the API, with alerts when new ones post.